| 2025 | 2024 | 2023 | ||||
|---|---|---|---|---|---|---|
| Gross margin | 426,5 k € | +23.6% | 345,0 k € | +28.8% | 267,8 k € | |
| EBITDA | 49,2 k € | +38.8% | 35,4 k € | +36.4% | 26,0 k € | |
| Operating profit | 48,8 k € | +37.8% | 35,4 k € | +36.4% | 26,0 k € | |
| Profit/loss | 35,4 k € | +46.5% | 24,2 k € | +27.5% | 19,0 k € | |
| Equity | 178,5 k € | +24.7% | 143,1 k € | +20.3% | 119,0 k € | |
| Total assets | 689,5 k € | -23.0% | 895,4 k € | +234.6% | 267,6 k € | |
| Cash | 66,4 k € | +453.0% | 12,0 k € | +29.4% | 9,3 k € | |
| Debts | 510,9 k € | -32.1% | 752,3 k € | +406.0% | 148,7 k € | |
| Staff | 3 | 3 | 2,6 | |||
Source: Belgian Official Gazette
Private limited company · Rotselaar · incorporated on 10/11/2022 · 3,0 ETP
Private limited company profitable and well capitalised. Cash position rising (+453.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
Biomedico is a Private limited company incorporated in 2022. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Rotselaar. It employs on average 3,0 ETP workers (FTE).